GI - 1002-CL-0101: A Study of ASP1002 in Adults for Treatment of Solid Tumors

The main aims of this study are:

• To check the safety of ASP1002 in people with certain solid tumors.
• To check if the people can tolerate ASP1002.
• To find a suitable dose of ASP1002. This study will be in 2 parts. In Part 1, different small groups of people will receive lower to higher doses of ASP1002. Any medical problems will be recorded at each dose. This is done to find suitable doses of ASP1002 to use in Part 2 of the study.

In Part 2, other different small groups of people will receive doses of ASP1002 that worked the best in Part 1.

Location(s): Hartford Hospital